Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Garcia Campelo, Maria Rosario; Zhou, Caicun; Ramalingam, Suresh S.; Lin, Huamao M.; Kim, Tae Min; Riely, Gregory J.; Mekhail, Tarek; Nguyen, Danny; Goodman, Erin; Mehta, Minal; Popat, Sanjay; Janne, Pasi A.

Publication Date

  • January 1, 2023

webpage

published in

category

keywords

  • carcinoma
  • lung neoplasms
  • mutation
  • neoplasm metastasis
  • non-small cell lung
  • quality of life

volume

  • 12

issue

  • 1